Description: America’s healthcare results are lackluster and worsening despite enormous effort and investment over many decades. Spending, affordability, health, coverage, access, quality, and healthcare workforce results are suboptimal or poor. Too many are suffering, and the system is financially unsustainable. We need a new approach, a new way of thinking about healthcare financing and delivery.

Description: This panel discussion will focus on how companies have been able to take advantage of the new US GAAP requirements, to develop and refine other performance indicators that provide additional insights into their business.

Description: Discuss a comparison of the U.S. general and insured population mortality experience and how COVID-19 and non-COVID-19 excess deaths impacted the populations differently. Discover the population mortality experience in the UK with a focus on the recent emergence of excess deaths for non-COVID causes. The long-term implications on the insured population will also be explored. Wrap up with a discussion of different conditions of long COVID, including organ impairments.

Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.

Description: This session will discuss the macro-economic impact (tariff/changing interest rate environment/government fiscal policy and etc.) on the insurance industry. We will relate this to the actuarial function such as corporate strategy/risk management/product pricing & marketing

Description: Recently, life insurers have seen a lot of change in their business model. Whether it be new accounting rules (e.g., long-duration targeted improvements [LDTI]) or new capital charges (e.g., structured equity tranche), companies are being forced to reconsider how they invest their assets. Today's session will help attendees understand how companies are using modelling software to help understand the impact of these changes on both their existing portfolio and potential changes that these new regulations may lead to. By attending, attendees will get a better understanding of: - How life insurers' asset allocation decisions are different than other financial companies (e.g., banks, pension funds, P&C companies) - How these changes may impact the risk vs. reward tradeoffs that life insurers' face - How these companies can use modelling software to help evaluate these potential impacts

Description: Attendees will learn how carriers and InsurTechs interact with private equity (PE), banks, and other investors who are increasingly interested in taking on traditional insurance risks. The introduction includes a review of recent large transactions, trends in InsurTech funding, and a primer on a typical transaction. There will also be a discussion amongst a panel of experts on the 'why' behind recent trends and future outlooks. Some specific questions we'll answer: Is this a good thing for the insurance industry? How are these trends impacted by interest rates? Where do actuaries fit in? How can a PE/bank investment be set up for success?

Description: Cost is a key outcome metric used by actuaries and others to determine the value of a benefit or program in health insurance. However, typically, costs assessed include only the direct costs of the program, not any indirect costs or savings, such as those associated with reduced spending on other services.

Description: For over a decade, the low interest rate environment in the U.S. has shaped the life insurance industry. Challenges in finding reasonable yields on investment-grade assets have defined insurer decisions on product designs and business mix. Now, we see a material shift in the interest rate environment, with the 10-year U.S. Treasury rate increasing nearly 3% from 2020 lows. In this follow-up to ImpACT 2021's popular Interest Rates May Be Rising...Now What Do We Do?, join us as we investigate the industry's response to the shifting interest rate environment with respect to pricing and product design, inforce and capital management, and the M&A and reinsurance markets. Have insurers been altering product designs and management actions to take advantage of the increased investment yield on long-term assets? Or are we seeing business-as-usual? How have the changes in rates impacted policyholder behavior? What are the benefit and risk of the rising interest rate for life insurers? We will also discuss developments in the M&A and closed block reinsurance market as (re)insurers continue to navigate the evolving economy. Gain an understanding of the impact that the new interest rate environment has had on life insurance and annuity pricing and product design, inforce and capital management, and the M&A and reinsurance markets.

Description: The NAIC is attempting to transition to a new economic scenario generator. The process has been ongoing for several years and many interesting challenges have emerged along the way. Get an overview of where this transition is at and what comparatives have been established between the existing and proposed economic scenario generators through scenario releases and field testing. A significant amount of discussion and investigation has been done concerning acceptance testing for interest rates, equities and corporate bond returns.